Overview

Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation

Status:
Unknown status
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to analysis of the pharmacokinetics of fludarabine for hematopoietic stem cell transplantation in pediatric patients.
Phase:
Phase 2
Details
Lead Sponsor:
Seoul National University Hospital
Collaborator:
Ministry of Food and Drug Safety, Korea
Treatments:
Fludarabine
Fludarabine phosphate
Vidarabine